| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.36 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |